Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
Coll freshman Avg
|
New words:
absent, affirmative, Africa, albumin, argued, ascribed, Athyrium, ATU, authoritative, Balkan, bandwidth, bifurcation, Blueprint, bridge, Cantor, carrier, chimeric, chylomicronemia, Circuit, Commonwealth, conflict, corridor, curable, cure, curve, derecognition, devaluation, East, Ecology, EMEA, Eurasia, evinacumab, explanatory, explicitly, extinguishment, fallen, FCS, Fitzgerald, foreclose, French, ga, GDPR, guarantor, hereof, hesitant, Highbridge, hourly, Intercreditor, intermittently, invention, irrevocable, junior, lattice, lender, licensee, lien, markup, meantime, mentioned, modestly, monoclonal, overly, pari, passu, path, PCT, pegylated, perfect, pled, pocket, post, pound, PPACA, prompt, quantum, rank, reconsider, Recordati, recourse, referendum, remit, remitted, repaid, resume, Russia, saving, scarce, solution, speculative, spread, standalone, strained, swap, swaption, thereunder, tolling, unamortized, unanimously, underwriting, unilaterally, unique, unremediated, untrue, usage, USPI, variation, wake
Removed:
AcquireCo, acyltransferase, Aguono, alliance, Aralez, Auxilium, Backstop, billed, bringing, CAD, central, committing, Composite, concurrently, DDSU, deadline, deductible, Deerfield, Delaware, detected, detection, determinable, developmental, diligent, dollar, DSU, Eligard, Endo, epithelium, exercisable, exercising, exploration, exploring, extract, fall, goodwill, graph, Greenhill, hinder, HoldCo, immune, incorporate, incorporating, index, informing, inherent, insite, IRD, JW, LCA, Leber, lecithin, leverage, locate, LRAT, MAA, Master, merged, minimize, multiplied, negligible, newly, partnering, passive, pertain, PFIC, photodynamic, physiologic, pigment, Pigmentosa, placement, POZEN, pro, promptly, proposal, proration, prospectively, quantifying, reflecting, reliably, relinquish, retinol, returning, RP, sensitivity, Simplifying, subscription, Suisse, Sun, tolmar, Tribute, understood, unqualified, USA, vision, Washington
Filing tables
Filing exhibits
Related press release
NVLN similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement Nos. 333-190221, 333-100070, 333-120657, 333-162465, 333-214907, 333-219587 and 333-219588 on Form S-8 and Registration Statement No. 333-214202 on Form S-3 of our report dated March 15, 2019, relating to the consolidated financial statements of Novelion Therapeutics Inc. and subsidiaries (the “Company”) (which report expresses an unqualified opinion and includes an explanatory paragraph referring to the substantial doubt about the Company’s ability to continue as a going concern) appearing in this Annual Report on Form 10-K of Novelion Therapeutics Inc. for the year ended December 31, 2018.
/s/ Deloitte & Touche LLP
Boston, Massachusetts
March 15, 2019